Morphine prolonged release

DRUG2 trials

Sponsors

Tris Pharma, Inc., Grünenthal GmbH

Conditions

Chronic PainNeoplasmsPain

Phase 2

A Study to Look at Tapentadol Tablets in Children and Adolescents in Pain

CompletedNCT02151682

Grünenthal GmbHPain

Start: 2015-04-29End: 2018-10-15Updated: 2019-09-12

Phase 3

CORAL - Cebranopadol Versus Morphine Prolonged-release in Patients With Chronic Moderate to Severe Pain Related to Cancer

TerminatedNCT01964378

Tris Pharma, Inc.Chronic Pain, Neoplasms, Pain

Start: 2013-10-29End: 2015-10-16Updated: 2021-07-15